Senti Biosciences Holdings Inc. Common Stock (SNTI)
Stock · NASDAQ · Health Care
$0.215as of 10/16/2026
Price chart
Active signals
SNTI Signal Track Record
How signals performed across all stocks →What SNTI's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 34 | -10.1% | 29% | September 23, 2026 |
| Bollinger Band Breakdown | 21 | -9.7% | 33% | July 15, 2026 |
| Bollinger Band Breakout | 16 | -26.7% | 19% | October 5, 2026 |
| 200-Day Moving Average TouchActive now | 6 | -20.7% | 33% | May 27, 2025 |
| Any 20-session window (baseline) | -9.7% | 34% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SNTI
Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company's lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications wit…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 39
- Website
- www.sentibio.com
Fundamentals
- 1-day range
- $0.2122$0.2531
- Market cap
- $11.18M
- P/E (trailing)
- —
- P/E (forward)
- -0.24
- EPS (trailing)
- $-1.76
- Dividend yield
- —
- Beta
- 2.28
- Avg. volume
- 782.8K
How Senti Biosciences Holdings Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 27, 2026 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
Senti Biosciences Holdings Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- SNTISenti Biosciences Holdings Inc. Common Stock$0.225▼ 14.12%Market cap $11.18MP/E —$0.2399$2.88
- INTSIntensity Therapeutics Inc. Common stock$3.35▼ 0.89%Market cap $11.49MP/E —$3.1$43.5
- BCDABioCardia Inc. Common Stock$0.92▼ 2.13%Market cap $10.80MP/E —$0.75$1.8
- INABIN8bio Inc. Common Stock$1.11▼ 6.33%Market cap $9.55MP/E —$0.88$2.73
- CRISCuris Inc. Common Stock$0.41▼ 19.61%Market cap $8.59MP/E —$0.5733$33.6
- PASGPassage Bio Inc. Common Stock$3.5▼ 2.78%Market cap $14.11MP/E —$3.29$20
- CELZCreative Medical Technology Holdings Inc. Common Stock$0.741▼ 9.39%Market cap $7.58MP/E —$0.62$6.25
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SNTI Senti Biosciences Holdings Inc. Common Stock | $11.18M | — | $0.225 | ▼ 14.12% | $0.2399$2.88 |
| INTS Intensity Therapeutics Inc. Common stock | $11.49M | — | $3.35 | ▼ 0.89% | $3.1$43.5 |
| BCDA BioCardia Inc. Common Stock | $10.80M | — | $0.92 | ▼ 2.13% | $0.75$1.8 |
| INAB IN8bio Inc. Common Stock | $9.55M | — | $1.11 | ▼ 6.33% | $0.88$2.73 |
| CRIS Curis Inc. Common Stock | $8.59M | — | $0.41 | ▼ 19.61% | $0.5733$33.6 |
| PASG Passage Bio Inc. Common Stock | $14.11M | — | $3.5 | ▼ 2.78% | $3.29$20 |
| CELZ Creative Medical Technology Holdings Inc. Common Stock | $7.58M | — | $0.741 | ▼ 9.39% | $0.62$6.25 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Senti Biosciences Says Stockholders Approve Merger With ST NewCo; Approve Reverse Split Ratio Of 1-For-20 To 1-For-50benzinga · 10/15/2026
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga · 9/29/2026
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga · 9/24/2026
- Senti Biosciences Files Prospectus Covering Resale Of Up To 25,555,024 Shares Of Common Stock Offered By The Selling SecurityholdersBenzinga · 9/24/2026
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga · 9/23/2026
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga · 9/17/2026
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga · 9/16/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
SNTI Included in List of Health Care Stocks Moving Pre-Market
Senti Biosciences was named in a Benzinga report listing 12 health care stocks showing movement during Tuesday's pre-market session. The stock is currently trading within a wide 52-week range of $0.29 to $2.88. This inclusion highlights short-term trading activity rather than a specific fundamental change.
SNTI Included in List of Health Care Stocks Moving Pre-Market. Senti Biosciences was named in a Benzinga report listing 12 health care stocks showing movement during Tuesday's pre-market session. The stock is currently trading within a wide 52-week range of $0.29 to $2.88. This inclusion highlights short-term trading activity rather than a specific fundamental change.